» Articles » PMID: 31859669

Feasibility and Safety of IUD Insertion by Mid-Level Providers in Sub-Saharan Africa

Overview
Date 2019 Dec 21
PMID 31859669
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Context: The copper IUD is safe and effective, but underutilized in Sub-Saharan Africa, in part because of a lack of trained providers. The World Health Organization recommends training mid-level providers-including nurses and midwives-to insert IUDs; however, the safety of such task shifting has not been evaluated in Sub-Saharan Africa.

Methods: Data were drawn from baseline surveys and study charts of 535 sexually active women aged 18-45 who used a copper IUD while participating in an HIV-prevention clinical trial conducted from August 2012 through June 2015 in Malawi, South Africa, Uganda and Zimbabwe. IUDs were inserted by study physicians, nurses and midwives trained as part of the trial, and by local nonstudy providers. Chi-square and Fisher's exact tests were used to compare women's experiences of adverse events-such as irregular bleeding, pelvic pain or device expulsion-by provider type.

Results: Half (54%) of women reported experiencing an adverse event; the most common were irregular bleeding and pelvic pain (45% and 25%, respectively). Compared with women who had received an IUD from a study physician or study nurse, greater proportions of women who had received one from a nonstudy provider reported any adverse event (76% vs. 49% and 51%, respectively), irregular bleeding (57% vs. 41% and 45%) and pelvic pain (35% vs. 15% and 32%); the difference between study physicians and nurses was significant only for pelvic pain. Expulsion rates were comparable for study nurses and nonstudy providers (12.3 and 11.9 per 100 woman-years, respectively), but lower for study physicians (7.3 per 100 woman-years).

Conclusions: The findings support task shifting of IUD insertion to mid-level providers to improve IUD access in Sub-Saharan Africa.

Citing Articles

Getting Up to Date with What Works: A Systematic Review on the Effectiveness and Safety of Task Sharing of Modern Methods in Family Planning Services.

Millogo T, Chomi E, Kouanda S, Ali M Biomed Res Int. 2023; 2023:8735563.

PMID: 36817856 PMC: 9936454. DOI: 10.1155/2023/8735563.


Uterine Artery Rupture Caused by IUD Extraction: A Case Report.

Wang N, Sun H Int J Womens Health. 2022; 14:831-836.

PMID: 35783676 PMC: 9249381. DOI: 10.2147/IJWH.S345712.


Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.

Browne E, Brown E, Palanee-Phillips T, Reddy K, Naidoo L, Jeenarain N J Acquir Immune Defic Syndr. 2022; 90(4):418-424.

PMID: 35344520 PMC: 9342948. DOI: 10.1097/QAI.0000000000002990.

References
1.
Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S . Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012; 367(5):411-22. PMC: 3687217. DOI: 10.1056/NEJMoa1202614. View

2.
Kaneshiro B, Aeby T . Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device. Int J Womens Health. 2010; 2:211-20. PMC: 2971735. DOI: 10.2147/ijwh.s6914. View

3.
Goldstuck N . Reducing barriers to the use of the intrauterine contraceptive device as a long acting reversible contraceptive. Afr J Reprod Health. 2015; 18(4):15-25. View

4.
Baeten J, Palanee-Phillips T, Brown E, Schwartz K, Soto-Torres L, Govender V . Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016; 375(22):2121-2132. PMC: 4993693. DOI: 10.1056/NEJMoa1506110. View

5.
Akin A, Gray R, Ramos R . Training auxiliary nurse-midwives to provide IUD services in Turkey and the Philippines. Stud Fam Plann. 1980; 11(5):178-87. View